Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyMcLaren Health Plan Medicaid Pharmaceutical Covera…
    Ask Trek AI about this page
    Currentmclaren health planPolicy 888-327-0671

    Pharmaceutical Management Medicaid 2026

    Customize your policy alerts

    Sign up for mclaren health plan Policy 888-327-0671 alerts

    Get alerted when Policy 888-327-0671 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs McLaren Health Plan's Medicaid drug formulary administration, coverage rules (including prior authorization, step therapy, quantity limits, specialty and compounded medications), and provider procedures for requesting exceptions. It applies to providers and members under McLaren Health Plan Medicaid.

    Policy Summary
    Payermclaren health plan
    PolicyPharmaceutical Management Medicaid 2026
    Policy CodePolicy 888-327-0671
    Change TypeRoutine review — no material changes noted
    Effective Date
    Last ReviewJan 1, 2024
    Next Review Date
    Key ActionSubmit a completed Medication Request/Prior Authorization form with clinical justification and relevant treatment history to MedImpact (fax or phone) for prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Common Formulary & SPDLPrimary formularies
    PA requiredPrior Authorization
    QL appliedQuantity Limits
    Compounds PACompounds

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    >=4x/yrReview Frequency

    Coverage Criteria and Medical Necessity

    Medical necessity and authorization criteria

    Covered when ALL of the following are met:

    Formulary alignment: Use of formulary drug products is preferred; non-formulary or brand requests require demonstration that formulary products are contraindicated or have failed.

    Based on Review Criteria items 1-3 (Formulary preferred; contraindication or trial/failure of formulary alternatives required).

    Prior authorization conditions: A prior authorization (PA) is required for medications identified with PA restriction and for compounded medications; approval must be obtained before pharmacy coverage except when emergency supply protocol is used.

    PA process: complete and fax the PA/Drug Exception Request form to MedImpact or call Customer Service for emergency supplies; see PA contact 888-274-9689 and Customer Service 888-327-0671.

    Step therapy: If a step therapy edit applies, the member must have tried and failed the required formulary alternatives unless those alternatives are medically contraindicated; documentation of trial/failure or contraindication must be provided with the PA request to override the step edit.

    ST edits define a sequence of medication alternatives; coverage for step-required medications is provided only after required alternatives have been tried and failed.

    Review criteria applied to requests: The prescribing provider must document that (1) formulary drug products are contraindicated, (2) the patient has failed an appropriate trial of formulary or related agents, and (3) available formulary choices are not suited for the patient and the selected drug is required for patient safety (or use of a formulary product would be detrimental).

    These items correspond to the policy's Review Criteria used when evaluating medication requests.

    Provider documentation and submission: Providers must complete the Medication Request/Prior Authorization form including patient and prescriber information, requested drug (name, dose, strength), diagnosis (ICD-10 if known), quantity, length of treatment, reason for request, other medications tried/failed, and pertinent history; then fax to MedImpact at the numbers on the form or contact the PA phone number for assistance.

    See Medication Request Form instructions and contact details on the PA form.

    Exclusions and non-covered uses: Medications not listed on the Michigan Pharmaceutical Product List (MPPL), items designated as MDHHS Carve-Out (billed to Fee‑for‑Service Medicaid), medications for cosmetic or convenience purposes, experimental or unproven uses, cough and cold products, sexual enhancement/ED, fertility‑promoting drugs, and non‑FDA regulated medical foods are excluded from coverage.

    Requests for excluded indications will be denied per non‑covered benefits policy.

    Quantity limits and dose optimization: Medications are subject to quantity limits (QL) and dose optimization as listed on the MHP Medicaid Drug Formulary; PA requests must reflect compliance with applicable QLs or provide justification for exceptions.

    Quantity limits may be specified per day, month, year, lifetime, or across a drug class.

    Site of care and benefit scope: Drug benefit does not reimburse for drug products acquired for, or administered at, inpatient hospital, outpatient hospital, emergency room/clinic, or physician office/clinic when billed outside the pharmacy benefit; ensure PA and billing align with site-of-care rules.

    Confirm appropriate billing route and site before submitting PA.

    Covered when ALL of the following are met: use of formulary drug products is preferred; requests for non‑formulary or brand products must demonstrate that formulary alternatives are contraindicated or have failed. Prior authorization is required for medications identified with PA restrictions and for compounded medications, and approval is required before pharmacy coverage unless an emergency supply protocol is used. If a step therapy edit applies, the member must have tried and failed the required formulary alternatives unless medically contraindicated. Providers must submit a completed Medication Request/Prior Authorization form with patient and prescriber information, the requested drug, diagnosis (ICD‑10 if known), quantity, duration, reason for request, prior medications tried/failed, and relevant history; then fax the form to MedImpact or call the PA contact for assistance.

    This policy does not cover medications that are not listed on the MPPL (Michigan Pharmaceutical Product List). Medications designated by MDHHS as Carve‑Out are not reimbursable by the plan and must be billed to Fee‑for‑Service (FFS) Medicaid. Medications prescribed for cosmetic or convenience purposes, experimental or unproven uses, cough and cold products, sexual enhancement/erectile dysfunction agents, fertility‑promoting medications, and medical foods or agents that are not regulated by the FDA are excluded from coverage.

    The drug benefit also does not reimburse for drug products acquired for, or administered at, an inpatient hospital, outpatient hospital, emergency room/clinic, or physician's office/clinic. Providers seeking coverage exceptions (including PA overrides for step therapy) must document contraindication to or failure of required formulary alternatives on the PA form and submit supporting clinical information per the PA instructions.

    Use of medications for cosmetic or convenience purposes and experimental or unproven uses are considered not medically necessary and are excluded from coverage. Examples called out in the policy include cough and cold products, sexual enhancement/erectile dysfunction medications, and fertility‑promoting drugs. Medical foods or agents not regulated by the FDA are also excluded.

    Medications identified by the Michigan Department of Health and Human Services as Carve‑Out must be billed to straight Fee‑for‑Service (FFS) Medicaid and are not reimbursable under McLaren Health Plan. For questions about carve‑out medications, providers may contact the Magellan Medicaid Beneficiary Help Line at the number listed by MDHHS.

    Coding and Diagnosis Requirements

    Requested diagnosis codesICD-10
    ICD-10Diagnosis code (if known) is requested on PA form
    Quantity Limits — formulary-specified QL rules
    What QL isQuantity Limits (QL) restrict medication amounts to promote safety, adherence, and cost control as listed on the MHP Medicaid Drug Formulary.
    Types of limitsSpecified quantity per day, month, or year; specified quantity per lifetime; specified quantity across a drug class.
    Where listedMedications with QL are identified on the MHP Medicaid Drug Formulary with a QL restriction.
    Exception processIf a prescriber feels a different quantity is medically necessary, submit a Prior Authorization (PA) request to the health plan for review.

    Provider Actions: Prior Authorization, Forms, and Submission

    Prior Authorization

    Submit completed PA/Drug Exception Request to MedImpact before coverage

    Certain medications identified with PA restrictions must have a completed Prior Authorization/Drug Exception Request form submitted to MedImpact for approval before pharmacy coverage; if questions or status updates are needed, contact MedImpact at 888-274-9689. For emergency supplies of a PA medication, contact Customer Service at 888-327-0671 for assistance.

    • Submit the completed PA/Drug Exception Request form (see form on page 5) by fax to the number on the form or call the PA contact.
    • PA is required when medications are identified with PA restriction to ensure safety or that a cost‑effective formulary alternative cannot be used.
    Step Therapy

    Enforce step therapy trials; use PA to request overrides with justification

    Step therapy edits require that the member trial and fail the defined formulary alternatives before MHP will cover step‑required medications; if alternatives are contraindicated or have failed, submit a PA to request an override with documentation supporting the medical necessity.

    Background and Policy Alignment

    This policy aligns McLaren Health Plan’s Medicaid Drug Formulary with the Michigan Medicaid Common Drug Formulary and the MDHHS Single Preferred Drug List to promote clinically appropriate, safe, and cost‑effective medication use. It applies to management of the Medicaid drug benefit including formulary decisions, prior authorization, step therapy, quantity limits, and specialty pharmacy processes.

    Specialty Pharmacy (SP) medications—defined as therapies used to treat complex medical conditions that may require special storage and handling (for example, cancer, endometriosis, hepatitis C, multiple sclerosis, osteoporosis, rheumatoid arthritis)—are managed under specialty pharmacy processes. Quantity limits and dose optimization are applied per the formulary to enhance safety and adherence.

    Definitions

    Specialty Pharmacy (SP) medications — definition and examples
    DefinitionSpecialty Pharmacy (SP) medications are used to treat complex medical conditions and may require special storage and handling.
    ExamplesCancer, endometriosis, hepatitis C, multiple sclerosis, osteoporosis, rheumatoid arthritis.
    ImplicationSP medications are managed under specialty pharmacy processes due to complexity and handling requirements.
    Carve-Out — MDHHS-identified carve-out medications
    DefinitionCarve-Out medications are those identified by MDHHS as not reimbursable under MHP and designated on the drug formulary as 'Carve Out'.
    BillingAny medication listed as Carve Out should be billed to straight Fee‑for‑Service (FFS) Medicaid.

    Step Therapy Requirements

    StepRequired formulary alternatives (trial/failure)Prior authorization override — allowable justification (examples)Provider action to request override
    {"text":"1","status":""},{"text":"Formulary drug alternatives as defined by MHP's step therapy edit (member must have tried and failed appropriate formulary or related agents)","status":""},{"text":"Documented contraindication to all required formulary alternatives; documented trial and failure of formulary or related agents; clinical necessity where formulary choices are not suited for patient safety or would provoke detrimental medical condition","status":""},{"text":"Submit completed Medication Request/Prior Authorization form with patient and prescriber information, diagnosis (ICD-10 if known), medications tried/failed, reason for request and supporting clinical documentation to MedImpact (fax or phone as listed on the form). For urgent needs, mark request as expedited per form instructions.","status":""}

    Quantity Limits and Restrictions

    Medications with QL as listed on formulary — specified quantity per period and class-wide limits
    ScopeMedications with QL are those identified on the MHP Medicaid Drug Formulary and subject to quantity restrictions.
    Per-period limitsMay be limited to a specified quantity per day, month, or year.
    Lifetime limitsMay be limited to a specified quantity per lifetime.
    Class-wide limitsMay be limited to a specified quantity across a drug class.
    Requesting exceptionPrescribers who believe a different quantity is medically necessary should submit a PA for review.

    Site of Care and Reimbursement Limitations

    Billing Rule

    Do not bill pharmacy benefit for drugs acquired/administered in hospital or clinic settings

    The drug benefit does not reimburse for drug products acquired for, or administered at, an inpatient hospital, outpatient hospital, emergency room/clinic, or physician's office/clinic; do not bill the drug benefit for products provided in these settings.

    • Do not seek pharmacy drug benefit reimbursement for medications acquired for or administered in hospital inpatient or outpatient settings, ER/clinic, or physician office/clinic.
    Policy Summary
    Payermclaren health plan
    PolicyPharmaceutical Management Medicaid 2026
    Policy CodePolicy 888-327-0671
    Change TypeRoutine review — no material changes noted
    Effective Date
    Last ReviewJan 1, 2024
    Next Review Date
    Key ActionSubmit a completed Medication Request/Prior Authorization form with clinical justification and relevant treatment history to MedImpact (fax or phone) for prior authorization.
    SourceLink
    On This Page
    Coverage Criteria and Medical NecessityCoding and Diagnosis RequirementsProvider Actions: Prior Authorization, Forms, and SubmissionBackground and Policy AlignmentDefinitionsStep Therapy RequirementsQuantity Limits and RestrictionsSite of Care and Reimbursement Limitations
    • ST edits define a sequence of medication alternatives; coverage provided only after required alternatives have been tried and failed.
    • Overrides of step therapy must be requested via the PA process with documentation that alternatives are contraindicated or unsuccessful.
    Documentation Required

    Complete and submit the Medication Request / Prior Authorization form with required fields

    Complete the Medication Request/Prior Authorization form in full before submission: include physician and patient identifiers, requested drug (name/dose/strength), diagnosis (ICD‑10 if known), quantity, length of treatment, reason for request, other medications tried/failed, and pertinent history; fax the form to MedImpact at (858) 790‑7100 or call (800) 788‑2949 for assistance.

    • Physician information fields: name, ID#, specialty, contact information, and diagnosis (ICD‑10 code if known).
    • Pharmacy/drug fields: requested drug name, dose, strength, quantity, dosage form, length of treatment, reason for request, prior medications tried/failed, and pertinent history.
    • Submit by fax to (858) 790‑7100 or call 1‑800‑788‑2949; address shown on form for Prior Authorization Department.
    Denial Risk

    Do not request coverage for non‑MPPL, cosmetic, experimental, or excluded site‑of‑care medications

    Do not expect coverage for medications not listed on the Michigan Pharmaceutical Product List (MPPL); medications prescribed for cosmetic/convenience purposes, experimental/unproven uses, cough/cold, sexual enhancement/ED, fertility drugs, or non‑FDA regulated medical foods are excluded and will be denied. Also note the drug benefit does not reimburse drugs acquired for or administered at inpatient/outpatient hospitals, emergency rooms/clinics, or physician offices/clinics.

    • Medications not on the MPPL are non‑covered and should not be submitted for PA.
    • Cosmetic/convenience uses and experimental/unproven indications are considered not medically necessary and excluded.
    • Do not bill the plan for drug products acquired for or administered in hospital/outpatient/emergency/physician clinic settings (not reimbursed).
    QuestionsFor questions regarding a Carve‑Out medication, contact the Magellan Medicaid Beneficiary Help Line at 877-681-7540.